|
News For CREE;ISRG;TPX;FFIV;MDRX From The Last 14 Days Check below for free stories on CREE;ISRG;TPX;FFIV;MDRX the last two weeks. |
|
|
| May 16, 2013 |
| 11:19 EDT |  | FFIV | F5 Networks spikes higher following Cisco's results, levels to watch
 Subscribe for More Information |
|
| May 14, 2013 |
| 17:48 EDT |  | ISRG | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). |
|
| 10:01 EDT |  | CREE | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital. |
|
| 10:01 EDT |  | MDRX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 07:36 EDT |  | CREE | Cree price target raised to $73 from $62 at Lazard Capital
Subscribe for More Information |
|
| 07:25 EDT | | CREE | Cree downgraded at Sterne Agee
As previously reported, Sterne Agee downgraded Cree to Neutral from Buy. The firm's checks indicate Philips Lighting North America has been aggressive in its marketing efforts forcing agents to choose between Philips and Cree lighting products. The analyst believes this will result in increased disruptions for Cree and lowered its price target to $59 from $66. |
|
| 06:17 EDT | | CREE | Cree downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information |
|
| 05:36 EDT | | MDRX | Allscripts upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
|
|
|
|
